Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer

Journals Menu

Follow SCIRP

ISSN Print: 2168-1589
ISSN Online: 2168-1597
www.scirp.org/journal/abcr
E-mail: abcr@scirp.org

Citations

"Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer"
written by Salah Mabrouk Khallaf, Jasmine Roshdy, Abeer Ibrahim,
published by Advances in Breast Cancer Research, Vol.9 No.2, 2020

has been cited by the following article(s):

[1]	Ligand-mediated nanomedicines against breast cancer: a review
	…, 2022

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top

[1]	Ligand-mediated nanomedicines against breast cancer: a review Nanomedicine, 2022 DOI:10.2217/nnm-2021-0473

[2]	Ligand-Mediated Nanomedicines Against Breast Cancer: A Review Nanomedicine, 2022 DOI:10.2217/nnm-2021-0473